Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Pardoll

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Biochimica Et Biophysica Acta|April 18, 1997
Maturation of cancer vaccines. A meeting report on 'Cancer Vaccines 1996,' sponsored by the Cancer Research Institute, held October 7-9, 1996D Pardoll
Current Opinion in Immunology|October 1, 1992
New strategies for active immunotherapy with genetically engineered tumor cellsD Pardoll
Nature|June 29, 2001
T cells and tumoursD Pardoll
Nature Medicine|August 1, 1997
Taming the sinister side of BMT: Dr. Jekyll and Mr. HydeD Pardoll
Current Opinion in Oncology|December 1, 1992
Immunotherapy with cytokine gene-transduced tumor cells: the next wave in gene therapy for cancerD Pardoll
Science (New York, N.Y.)|March 22, 1996
Releasing the brakes on antitumor immune responseD Pardoll
Current Opinion in Immunology|April 1, 1992
Thymic selectionD Pardoll, A Carrera
Journal of Virology|November 1, 1976
Evidence that mismatched bases in heteroduplex T4 bacteriophage are recognized in vivoH Berger, D Pardoll
Cancer Research|November 1, 1995
Regression of established tumors in mice mediated by the oral administration of a recombinant Listeria monocytogenes vaccineZ K Pan, G Ikonomidis, D Pardoll, et al.
European Journal of Immunology|August 1, 1992
Molecular analysis of a pro-T cell clone transformed by Abelson-murine leukemia virus, displaying progressive gamma delta T cell receptor gene rearrangement and surface expressionF Heuze, D Pardoll, E Diez, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Biochimica Et Biophysica Acta|April 18, 1997
Maturation of cancer vaccines. A meeting report on 'Cancer Vaccines 1996,' sponsored by the Cancer Research Institute, held October 7-9, 1996D Pardoll
Current Opinion in Immunology|October 1, 1992
New strategies for active immunotherapy with genetically engineered tumor cellsD Pardoll
Nature|June 29, 2001
T cells and tumoursD Pardoll
Nature Medicine|August 1, 1997
Taming the sinister side of BMT: Dr. Jekyll and Mr. HydeD Pardoll
Current Opinion in Oncology|December 1, 1992
Immunotherapy with cytokine gene-transduced tumor cells: the next wave in gene therapy for cancerD Pardoll
Science (New York, N.Y.)|March 22, 1996
Releasing the brakes on antitumor immune responseD Pardoll
Current Opinion in Immunology|April 1, 1992
Thymic selectionD Pardoll, A Carrera
Journal of Virology|November 1, 1976
Evidence that mismatched bases in heteroduplex T4 bacteriophage are recognized in vivoH Berger, D Pardoll
Cancer Research|November 1, 1995
Regression of established tumors in mice mediated by the oral administration of a recombinant Listeria monocytogenes vaccineZ K Pan, G Ikonomidis, D Pardoll, et al.
European Journal of Immunology|August 1, 1992
Molecular analysis of a pro-T cell clone transformed by Abelson-murine leukemia virus, displaying progressive gamma delta T cell receptor gene rearrangement and surface expressionF Heuze, D Pardoll, E Diez, et al.
Pageof 3